Status:
COMPLETED
Using Immersive Virtual Reality to Treat Pediatric Anxiety
Lead Sponsor:
Johns Hopkins University
Conditions:
Specific Phobia
Specific Phobia, Situational
Eligibility:
All Genders
8-17 years
Phase:
NA
Brief Summary
Anxiety is a common and impairing problem for children. The principle treatment for pediatric anxiety involves facing a child's fears in a stepwise approach through a therapeutic exercise called expos...
Eligibility Criteria
Inclusion
- 8-17 years (inclusive),
- meet diagnostic criteria for one or more phobias on a structured diagnostic interview (ADIS-C/P). This specifically includes natural environments (e.g., storms, heights) and/or situational settings (e.g., airplanes, public speaking).
- be fluent in English.
Exclusion
- unable to complete rating scales, or
- attend study visits.
Key Trial Info
Start Date :
September 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 14 2023
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT04504773
Start Date
September 17 2020
End Date
February 14 2023
Last Update
February 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States, 21205